Publication | Open Access
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS
118
Citations
28
References
2020
Year
| Year | Citations | |
|---|---|---|
2016 | 2K | |
2014 | 1.4K | |
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham, AllergyAtopic DermatitisAllergy MedicineModerate-to-severe Atopic DermatitisSkin Allergy | 2017 | 1.2K |
2017 | 996 | |
2009 | 947 | |
2013 | 937 | |
2018 | 849 | |
2004 | 626 | |
2011 | 626 | |
2013 | 596 |
Page 1
Page 1